Method for lowering plasma levels of lipoprotein (a)
Patent 5489611 Issued on February 6, 1996. Estimated Expiration Date: 
February 10, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
February 10, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesUse of retinoids for the treatment of coronary artery disease Patent #: 5219888 InventorsApplicationNo. 388043 filed on 02/10/1995US Classes:514/557, Carboxylic acid, percarboxylic acid, or salt thereof (e.g., peracetic acid, etc.)514/703, Carbon to carbon unsaturation514/725, Vitamin A compound or derivative514/824ARTERIOSCLEROSISExaminersPrimary: Jordan, KimberlyAttorney, Agent or FirmInternational ClassesA61K 031/19A61K 031/11 A61K 031/07 AbstractRetinoids are effective to lower plasma levels of Lp (a) in mammals.Other References
| |
